Coronavirus: WHO tells doctors don’t use Gilead’s remdesivir, splitting with FDA

A WHO panel advised doctors against using Gilead Sciences’ antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19.

The group said there is currently “no evidence” that it improves survival rates or the need for ventilation.

The recommendation was published in the British medical trade journal The BMJ on Friday in the EU.

CNBC Coronavirus: WHO tells doctors don’t use Gilead’s remdesivir, splitting with FDA

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.